🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Norway
Clinical trial register · Norway

Studies with a Norwegian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1251 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:45 UTC
1251
Studies in scope
all four open statuses
670
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
Oslo 720 Bergen 323 Trondheim 255 Tromsø 143 Stavanger 123
Narrow the register
Recruitment status
Phase
Lead sponsor
Oslo University Hospital182 Haukeland University Hospital83 Norwegian University of Science and Technology65 St. Olavs Hospital47 University Hospital, Akershus32
Site location
Oslo720 Bergen323 Trondheim255 Tromsø143 Stavanger123
All 107 locations
Target enrolment
to

Trials in this register

1251 of 1251 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Active, closed
Optilume Registry for Treatment of Stricture of the Anterior Urethra
NCT05479422Anterior Urethral Stricture, Male
European Association of Urology Research Foundation
Observational
150
Oslo
2022-10-13
Active, closed
Expert@Work - Effectiveness of a Digital Expert Team on Return to Work
NCT05575908Musculoskeletal Diseases, Mental Disorder
St. Olavs Hospital
Not applicable
170
Ålesund, Levanger, Molde, Trondheim
2022-10-13
Recruiting
Embolization for Meningioma
NCT05416567Meningioma
St. Olavs Hospital
Not applicable
30
Trondheim
2022-10-10
Active, closed
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin
NCT05504252Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma
DrugsOpdivo·Adrucil·Nivolumab·Oxaliplatin
University Hospital, Akershus
Phase 2
80
Lørenskog, Oslo, Trondheim
2022-10-05
By invitation
Mindfulness and Eating Disorder Symptoms
NCT05539807Eating Disorders
University of Bergen
Not applicable
197
Bergen
2022-10-01
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035Acute Myeloid Leukemia
DrugsGemtuzumab Ozogamicin·Cytarabine·Azacitidine·Fludarabine
PedAL BCU, LLC
Phase 3
130
Oslo
2022-10-01
Active, closed
Green Approach to Improved Nutritional Support for Cancer Patients
NCT05544318Malnutrition
University of Oslo
Not applicable
130
Oslo
2022-10-01
Active, closed
Remote Care in People With Rheumatoid Arthritis
NCT05496855Rheumatoid Arthritis
Diakonhjemmet Hospital
Not applicable
228
Oslo
2022-09-29
Recruiting
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
NCT05421143Multimorbidity
Malin Olsen Syversen
Observational
240
Oslo
2022-09-29
Recruiting
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
NCT05476939Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Midline Glioma, H3K27-altered
DrugsDordaviprone·Everolimus
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
433
Oslo
2022-09-29
Active, closed
NOPARK Open Label Extension Study
NCT05546567Safety Issues
Haukeland University Hospital
Not applicable
400
Bergen
2022-09-28
Recruiting
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
NCT05725200Metastatic Colorectal Cancer
DrugsIdelalisib·Crizotinib·Encorafenib·Alectinib
Oslo University Hospital
Phase 2
40
Oslo
2022-09-27
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484Colitis, Ulcerative
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
577
Ålesund, Gjettum, Gjøvik, Lørenskog, Oslo, Tromsø
2022-09-19
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Bergen, Oslo, Tromsø, Trondheim
2022-09-19
Recruiting
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
NCT04628026Acute Myeloid Leukemia
DrugVenetoclax
University of Ulm
Phase 3
650
Bergen, Oslo, Tromsø, Trondheim
2022-09-13
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797Multiple Myeloma
DrugsTeclistamab·Lenalidomide
European Myeloma Network B.V.
Phase 3
1,594
Trondheim
2022-09-08
By invitation
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
NCT05610423Myocarditis
Oslo University Hospital
Observational
100
Oslo
2022-09-01
Recruiting
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
NCT05689775Perineum; Wound, Postoperative Complications, Rectal Neoplasms, Rectus Abdominis Hernia
Oslo University Hospital
Observational
40
Oslo
2022-09-01
By invitation
The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals
NCT05740111Hereditary Pancreatic Cancer
Oslo University Hospital
Not applicable
200
Oslo
2022-09-01
Active, closed
Effect of Exercise Training on Breastmilk Composition
NCT05488964Obesity
Norwegian University of Science and Technology
Not applicable
62
Trondheim
2022-09-01
Active, closed
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
NCT07150104Multiple Myeloma
DrugsNirogacestat·Belantamab mafodotin·Pomalidomide·Dexamethasone
GlaxoSmithKline
Phase 1/2
14
Oslo
2022-08-31
Recruiting
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
NCT05245877Pancreas Cancer, Pancreas Neoplasm, Surgery, Thrombosis
Helsinki University Central Hospital
Phase 4
800
Oslo
2022-08-17
By invitation
MDR ExploR Radial Head System PMCF
NCT05583448Elbow Injury
Zimmer Biomet
Observational
93
Lørenskog
2022-08-16
Recruiting
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
NCT05344209Oncology, NSCLC Stage IV, NSCLC, Stage III
DrugsUV1·Leukine
Vestre Viken Hospital Trust
Phase 2
138
Drammen
2022-08-12
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471Crohn's Disease
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
703
Ålesund, Gjettum, Lørenskog, Oslo, Tromsø
2022-07-22
Recruiting
The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma
NCT05447273Penile Cancer
Oslo University Hospital
Observational
60
Oslo
2022-07-15
Active, closed
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
NCT05217446Metastatic Colorectal Cancer
DrugsEncorafenib·Erbitux·Cetuximab·Keytruda
Pfizer
Phase 2
108
Oslo
2022-07-11
Active, closed
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970Nonsquamous Non-small Cell Lung Cancer, EGFR L858R, EGFR Exon 19 Deletion
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 3
586
Lørenskog, Oslo, Stavanger
2022-07-08
Active, closed
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
NCT05286294Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, MSI-High
DrugFecal Microbiota Transplant
Oslo University Hospital
Phase 2
20
Oslo
2022-06-28
Active, closed
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
NCT05186753SSM, Mastocytosis, Indolent, Mastocytosis, Systemic, Mastocytosis
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
237
Oslo
2022-06-27
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone
Celgene
Phase 3
939
Bergen, Oslo, Trondheim
2022-06-23
Active, closed
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
NCT05405166Plasma Cell Myeloma Recurrent
DrugsParacetamol / Acetaminophen·Montelukast·Diphenhydramine·Isatuximab
Sanofi
Phase 3
531
Ålesund, Oslo
2022-06-23
Recruiting
Monitoring of Chronic Conditions in Breast Cancer
NCT05587777Breast Cancer, Chronic Fatigue Syndrome
Helse Stavanger HF
Observational
150
Stavanger
2022-06-15
Active, closed
Early Psychological Intervention After Rape
NCT05489133Post Traumatic Stress Disorder, Rape Sexual Assault, Sexual Dysfunctions, Psychological, Pelvic Floor Myalgia
St. Olavs Hospital
Not applicable
166
Stavanger, Oslo, Sandefjord, Trondheim
2022-06-14
Active, closed
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
NCT05321706Heart Transplant Failure, Kidney Failure
DrugsFarxiga·Dapagliflozin
Oslo University Hospital
Phase 3
430
Oslo
2022-06-08
Recruiting
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
NCT05477589Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
Vastra Gotaland Region
Phase 3
170
Oslo
2022-06-07
Recruiting
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
NCT05368090Primary Aldosteronism, Aldosterone-Producing Adenoma, Hypercortisolism
Haukeland University Hospital
Not applicable
60
Bergen
2022-06-03
Recruiting
Investigating Myocardial Remodelling in the Failing Human Heart
NCT05303896Heart Failure
Oslo University Hospital
Observational
200
Oslo
2022-05-30
Recruiting
A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment
NCT04917601Childhood Obesity, Adolescent Obesity, mHealth, Personalized Medicine
Karolinska Institutet
Not applicable
680
Trondheim
2022-05-24
Recruiting
Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD)
NCT05177055Delayed Sleep-Wake Phase Disorder, Sleep Disorder, Psychiatric Disorder
Haukeland University Hospital
Not applicable
60
Bergen
2022-05-23
Active, closed
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT05269004Multiple Sclerosis
DrugOcrelizumab
Hoffmann-La Roche
Phase 3
1,300
Bergen
2022-05-03
Active, closed
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
NCT05280548Fabry Disease
DrugsAgalsidase beta·Replagal·Venglustat·Migalastat HCl
Sanofi
Phase 3
104
Bergen
2022-05-03
Active, closed
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
NCT05270044Melanoma
Pierre Fabre Medicament
Phase 3
815
Ålesund, Oslo
2022-05-02
Active, closed
Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project)
NCT05269225Nutrition
Per Ole Iversen, MD
Not applicable
100
Oslo
2022-05-02
Active, closed
Effect of Breastfeeding on Lipid Profile and Cardiovascular Risk Markers in Women With Familial Hypercholesterolemia
NCT05367310Familial Hypercholesterolemia
Oslo University Hospital
Observational
50
Oslo
2022-05-01
Recruiting
Predictors of Failed Thrombolysis in Acute Myocardial Infarction
NCT05347732STEMI - ST Elevation Myocardial Infarction
Oslo University Hospital
Observational
200
Oslo
2022-04-25
Recruiting
NorMIGS - a Study of Micro-invasive Glaucoma Surgery
NCT05340647Glaucoma
Oslo University Hospital
Observational
100
Oslo
2022-04-22
Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
NCT05208047Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
DrugsBezuclastinib·Sunitinib·Midazolam
Cogent Biosciences, Inc.
Phase 3
482
Bergen, Oslo
2022-04-14
Active, closed
A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome
NCT05306548Carpal Tunnel Syndrome
Diakonhjemmet Hospital
Phase 4
258
Lørenskog, Oslo, Sandvika
2022-04-08
Active, closed
Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco
NCT05290025Smoking Cessation, Substance-Related Disorders
DrugNicotine
Haukeland University Hospital
Not applicable
266
Bergen, Stavanger
2022-04-07
Recruiting
Drug-free Without Toothache. A Study of Free Dental Treatment as a Part of Substance Abuse Treatment
NCT05606562Substance Abuse, Dental Caries
University Hospital of North Norway
Not applicable
50
Narvik
2022-04-06
Recruiting
Scandinavian Humeral Diaphyseal Fracture Trial
NCT04574336Fracture Humerus of Shaft
Kolding Sygehus
Not applicable
287
Oslo, Stavanger
2022-04-04
Active, closed
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)
NCT05270668Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease
DrugTulisokibart
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Oslo
2022-03-29
Recruiting
Tailoring Treatment in Colorectal Cancer
NCT05401318Colorectal Neoplasms
University Hospital, Akershus
Observational
40
Lørenskog
2022-03-28
Active, closed
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
NCT05317416Multiple Myeloma
DrugsElranatamab·Lenalidomide
Pfizer
Phase 3
854
Oslo, Stavanger
2022-03-25
Active, closed
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559Haemophilia A and B With and Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
153
Oslo
2022-03-24
Active, closed
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
NCT05143138Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
W.L.Gore & Associates
Observational
259
Bergen, Tromsø, Trondheim
2022-03-23
Recruiting
A 3-day Course for CFS/ME
NCT05236465Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Norwegian University of Science and Technology
Not applicable
100
Trondheim
2022-03-21
Recruiting
Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis
NCT05291819Psoriatic Arthritis
Diakonhjemmet Hospital
Not applicable
202
Ålesund, Bergen, Drammen, Førde, Haugesund, Kristiansand, Lillehammer, Mo i Rana
2022-03-14
Active, closed
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
NCT05206773Fabry Disease
DrugVenglustat
Sanofi
Phase 3
122
Bergen
2022-03-11
Active, closed
The National Lipedema Study
NCT05284266Lipedema
Haraldsplass Deaconess Hospital
Not applicable
220
Bergen
2022-03-11
Recruiting
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
NCT06757517Benzodiazepine Dependence
DrugOxytocin
St. Olavs Hospital
Phase 2
60
Trondheim
2022-03-01
Active, closed
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
NCT05211895Non-Small Cell Lung Cancer
DrugsDomvanalimab·Durvalumab
AstraZeneca
Phase 3
791
Bodø, Gjøvik, Oslo, Trondheim
2022-02-18
Active, closed
Effect of Physical Activity and Pain Education on Endometriosis-associated Pain
NCT05091268Endometriosis
University Hospital, Akershus
Not applicable
83
Lillestrøm
2022-02-15
Active, closed
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
NCT05173987Endometrial Neoplasms
DrugsTaxotere·Paraplatin·Taxol·Keytruda
Merck Sharp & Dohme LLC
Phase 3
280
Oslo
2022-02-03
Active, closed
Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach
NCT04900506Femoral Neck Fractures, Bone Mineral Density, Muscle Damage, Surgical Approach
Sorlandet Hospital HF
Not applicable
210
Arendal, Kristiansand
2022-01-21
Recruiting
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
NCT05190172Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant
Oslo University Hospital
Not applicable
225
Oslo
2022-01-14
Recruiting
Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
NCT05243082Pancreatic Neuroendocrine Tumors, WHO Grade I-II
Oslo University Hospital
Not applicable
20
Oslo
2022-01-14
Recruiting
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
NCT05218785Plantar Fascitis, Gastrocnemius Tightness
DrugBotox
Oslo University Hospital
Observational
40
Oslo
2022-01-13
Recruiting
Antibiotic Therapy in Viral Airway Infections
NCT05045612Infectious Disease, Influenza, Respiratory Syncytial Virus (RSV), Respiratory Tract Infections
University Hospital, Akershus
Phase 4
380
Bergen, Drammen, Gjettum, Grålum, Kristiansand, Lørenskog, Oslo, Skien
2022-01-13
Recruiting
Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs
NCT05750095Autism Spectrum Disorder
Haukeland University Hospital
Not applicable
240
Bergen, Haugesund, Trondheim
2022-01-10
Recruiting
Dietary Strategies for Remission of Type 2 Diabetes
NCT04943926Diabetes Mellitus, Type 2, Overweight and Obesity, Hypertension, Glucose Intolerance
University of Bergen
Not applicable
600
Bergen
2022-01-04
Recruiting
Hallux Valgus- Radiological and Clinical Predictors for Outcome After Surgery
NCT04851249Hallux Valgus
Ostfold Hospital Trust
Observational
250
Sarpsborg
2022-01-01
Active, closed
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT04819100Carcinoma, Non-Small-Cell Lung
DrugSelpercatinib
Eli Lilly and Company
Phase 3
152
Oslo
2021-12-20
Recruiting
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
NCT04463498Sleep Disorder; Insomnia Type, Psychiatric Disorders
Haukeland University Hospital
Not applicable
60
Bergen
2021-12-17
Active, closed
Ablation vs Resection of Colorectal Cancer Liver Metastases
NCT05129787Colorectal Cancer Metastatic
Oslo University Hospital
Not applicable
230
Oslo
2021-12-16
Active, closed
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
NCT05214183MCL, Mantle Cell Lymphoma
Nordic Lymphoma Group
Phase 2
81
Bergen, Oslo, Stavanger, Trondheim
2021-12-15
Recruiting
A Pilot Study for Optimizing Meropenem Administration in the ICU
NCT05578586Drug Effect
DrugMeropenem
Oslo University Hospital
Not applicable
50
Oslo
2021-12-14
Active, closed
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
NCT05116189Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
DrugsDocetaxel·Paclitaxel·Bevacizumab·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
643
Tromsø
2021-12-13
Active, closed
Invest-CTO PCI Trial
NCT04774913Chronic Total Occlusion of Coronary Artery, Angina Pectoris, Quality of Life, PROM
Haukeland University Hospital
Not applicable
200
Bergen
2021-12-08
Recruiting
Early Infant Micronutrition and Development
NCT05005897Vitamin B 12 Deficiency
Sykehuset Innlandet HF
Phase 2/3
600
Lillehammer
2021-12-08
Active, closed
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
NCT04821284Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8
DrugsLeucovorin Calcium·Abraxane·Daunorubicin·5-FU
Flemming Forsberg
Phase 1/2
120
Bergen
2021-12-06
By invitation
Extension Study of Infigratinib in Children With Achondroplasia (ACH)
NCT05145010Achondroplasia
DrugInfigratinib
QED Therapeutics, a BridgeBio company
Phase 2
300
Bergen, Oslo
2021-12-06
Active, closed
Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial
NCT05030922Nutrition
Per Ole Iversen, MD
Not applicable
538
Oslo
2021-12-01
By invitation
Applying Artificial Intelligence in Developing Personalized and Sustainable Healthcare for Spinal Disorders
NCT05745129Low Back Pain, Neck Pain, Disc Herniation, Disc Degeneration
Oslo Metropolitan University
Observational
165,000
Oslo
2021-12-01
Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
NCT04910685Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis
Blueprint Medicines Corporation
Phase 2/3
534
Oslo
2021-11-30
Active, closed
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
NCT05030428Atherosclerotic Cardiovascular Disease
DrugInclisiran sodium
Novartis Pharmaceuticals
Phase 3
17,004
Nordbyhagen, Arendal, Drammen, Oslo, Skedsmokorset, Stavanger, Tromsø
2021-11-23
Active, closed
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)
NCT05130450Familial Chylomicronemia Syndrome
DrugOlezarsen
Ionis Pharmaceuticals, Inc.
Phase 3
60
Oslo
2021-11-18
Active, closed
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925Primary Immune Thrombocytopenia
DrugEfgartigimod PH20
argenx
Phase 3
173
Sarpsborg
2021-11-17
Active, closed
Intensive Care of Elderly: What do They Wish for Themselves?
NCT05149040Aged, 80 and Over, Critical Illness
Haukeland University Hospital
Observational
1,472
Bergen
2021-11-15
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Oslo
2021-11-09
Recruiting
Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
NCT05186493Locally Advanced Pelvic Cancer That Require Pelvic Exenteration
Oslo University Hospital
Not applicable
40
Oslo
2021-11-01
Active, closed
Investigation of Factors Associated With Preserved Cognitive Function in Bipolar Disorder
NCT04454073Bipolar Disorder
St. Olavs Hospital
Observational
87
Trondheim
2021-10-29
Active, closed
Effect of Early Assessment Team for Patients Referred to Outpatient Mental Health Care
NCT05087446Mental Disorder
St. Olavs Hospital
Not applicable
588
Trondheim
2021-10-26
Active, closed
Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial
NCT05118828Anxiety, Mild to Moderate Depression
Norwegian Institute of Public Health
Not applicable
1,000
Brekstad, Kopervik, Leknes, Notodden, Sandnes, Vikersund
2021-10-20
Recruiting
Biomarkers for Ventilator-associated Pneumonia
NCT05117125Pneumonia, Ventilator-Associated
Region Skane
Observational
1,000
Drammen
2021-10-15
Active, closed
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 3
123
Oslo
2021-10-14
Recruiting
Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures
NCT04868305Hip Injuries and Disorders, Hip Fractures
Helse Stavanger HF
Not applicable
170
Stavanger
2021-10-12
Active, closed
Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses
NCT04960787Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
SWOG Cancer Research Network
Not applicable
331
2021-10-12
Active, closed
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
NCT05095571Amyotrophic Lateral Sclerosis
Haukeland University Hospital
Not applicable
300
Bergen, Bodø, Drammen, Førde, Haugesund, Kristiansand, Lillehammer, Lørenskog
2021-10-07
Rows per page Showing 701–800 of 1251
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-norway?page=8

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,251 studies in total at the last sync on 26 Sep 2026, 19:45 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Norway?

670 of the 1,251 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:45 UTC sync. A further 63 have not yet opened recruitment, 453 are active but closed to new participants, and 65 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Multiple Myeloma (30) Obesity, Morbid (24) Colorectal Cancer (19) Prostate Cancer (15) Quality of Life (13) Breast Cancer (13) Cancer (11) Cardiovascular Diseases (11) Stroke (10) Heart Failure (10) Depression (9) Anxiety (9) Crohn's Disease (9) Endometrial Cancer (9) Eating Disorders (8)
→

Browse trials by site location

Oslo (720) Bergen (323) Trondheim (255) Tromsø (143) Stavanger (123) Lørenskog (96) Drammen (89) Kristiansand (56) Ålesund (54) Bodø (37) Tønsberg (36) Grålum (32) Lorenskog (25) Arendal (24) Haugesund (24)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.